AIM ImmunoTech, Inc. (AIM)
0.5556
+0.01
(+1.81%)
USD |
NYAM |
Apr 16, 16:00
0.5556
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Cash from Investing (Quarterly) : -0.095M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agenus, Inc. | 0.78M |
| Curis, Inc. | 2.50M |
| Plus Therapeutics, Inc. | -1.077M |
| Windtree Therapeutics, Inc. | -0.789M |
| Halozyme Therapeutics, Inc. | -741.79M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.986M |
| Cash from Financing (Quarterly) | 2.719M |
| Free Cash Flow | -11.34M |
| Free Cash Flow Per Share (Quarterly) | -0.6772 |
| Free Cash Flow to Equity (Quarterly) | -4.639M |
| Free Cash Flow to Firm (Quarterly) | -1.69M |
| Free Cash Flow Yield | -107.0% |